These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26964465)

  • 1. [REFERENCE RANGES OF ANTITHROMBINE III IN ASSOCIATION WITH THE USE OF A STA COMPACT AUTOMATED COAGULOMETER].
    Petrova OV; Urtaeva ZA; Gordeeva OB; Shashin SA; Tarasov DG
    Klin Med (Mosk); 2015; 93(10):43-6. PubMed ID: 26964465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant proteins in a population of Mexican mestizo donors.
    Meillón-García LA; Hernández-Zamora E; Montiel-Manzano G; Zavala-Hernández C; Ramírez-San Juan E; Cesarman-Maus G; Reyes-Maldonado E
    Ann Vasc Surg; 2015 Feb; 29(2):222-6. PubMed ID: 25463331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The reference intervals of antithrombin III in population of the Astrakhanskaia oblast at application of automated coagulometers.].
    Petrova OV; Urtaieva ZA; Shashin SA; Murygina OI; Tarasov DG
    Klin Lab Diagn; 2016; 61(7):429-432. PubMed ID: 31529924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 6. An evaluation of antithrombin III laboratory tests.
    King PG; Huang AH; Palkuti HA; Farris VL
    Am J Clin Pathol; 1980 Apr; 73(4):537-40. PubMed ID: 7369177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J; Fareed J; Bermes EW
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation testing with the Du Pont aca discrete clinical analyzer.
    Pierson-Perry JF; Wehrly JA; Siefring GE
    Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
    Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-thrombin III levels in some Malaysian patients suspected of having acquired coagulation disorders.
    Tan SH; Doraisamy G; Noriah R; Lopez CG
    Singapore Med J; 1983 Feb; 24(1):33-6. PubMed ID: 6867763
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the STA (serum thrombotic accelerator) activity, with special reference to changes in the STA activity in the serum from patients with hypercoagulable state. 1. Experimental study].
    Nakamura Y
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):245-55. PubMed ID: 5530048
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of automation in the development of reagents and kits for automated methods in coagulation testing.
    Martinoli JL; Amiral J
    Semin Thromb Hemost; 1983 Jul; 9(3):194-205. PubMed ID: 6351254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the xylum clot signature analyzer in normal subjects and patients with the Hermansky-Pudlak syndrome.
    Horne MK; Williams SB; Gahl WA; Rick ME
    Thromb Res; 2001 Oct; 104(1):57-63. PubMed ID: 11583739
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electrocoagulography using integral indices in assessing hemostatic disorders in children].
    Baranov AA
    Anesteziol Reanimatol; 1988; (6):59-61. PubMed ID: 3245625
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation parameters as prognostic factors in multiple trauma: can clinical values be an early diagnostic aid?].
    Lampl L; Helm M; Specht A; Bock KH; Hartel W; Seifried E
    Zentralbl Chir; 1994; 119(10):683-9. PubMed ID: 7801706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [STA (serum thrombotic accelerator) activity, with special reference to changes in the STA activity in the serum from patients with hypercoagulable state. 2. Clinical studies].
    Nakamura Y
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):256-72. PubMed ID: 5530049
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].
    Priĭmak AA; Makinskiĭ AI; Ivan'ko TP; Makarova VV
    Vrach Delo; 1990 May; (5):73-4. PubMed ID: 2396401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.